These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21471973)

  • 1. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension.
    Yamada Y; Tsuboi K; Hattori T; Murase T; Ohtake M; Furukawa M; Ueyama J; Nishiyama A; Murohara T; Nagata K
    Hypertens Res; 2011 Jul; 34(7):809-16. PubMed ID: 21471973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of the combination of nifedipine and losartan in hypertensive Dahl salt-sensitive rats.
    Tinel H
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):75-82. PubMed ID: 17666919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
    Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.
    Kjeldsen SE; Lyle PA; Kizer JR; Oparil S; Høieggen A; Os I
    Vasc Health Risk Manag; 2007; 3(3):299-305. PubMed ID: 17703637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and effect on plasma B-type natriuretic peptide concentration of losartan-hydrochlorothiazide for hypertension uncontrolled by losartan-based therapy: subanalysis of a Multicentre Prospective Observational Study.
    Meno H; Inou T; Tanaka M; Tsuchiya Y; Shiga Y; Kobayashi K; Nakamura Y; Ota T; Kubara I
    Arzneimittelforschung; 2012 Sep; 62(9):414-9. PubMed ID: 22773432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
    Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
    Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
    Liang B; Leenen FH
    J Cardiovasc Pharmacol; 2008 May; 51(5):457-66. PubMed ID: 18418273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benazepril combined with either amlodipine or hydrochlorothiazide is more effective than monotherapy for blood pressure control and prevention of end-organ injury in hypertensive Dahl rats.
    Zhou MS; Jaimes EA; Raij L
    J Cardiovasc Pharmacol; 2006 Jul; 48(1):857-61. PubMed ID: 16891915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X; Matavelli LC; Ono H; Frohlich ED
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension.
    Ito H; Ishii K; Kihara H; Kasayuki N; Nakamura F; Shimada K; Fukuda S; Iwakura K; Yoshikawa J;
    Hypertens Res; 2012 Jan; 35(1):93-9. PubMed ID: 22011686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of estimated salt excretion as a possible predictor of the efficacy of concomitant angiotensin receptor blocker (ARB) and low-dose thiazide in patients with ARB resistance.
    Hasegawa H; Kanozawa K; Asakura J; Takayanagi K; Komuro O; Fukada H; Tokushima H; Kogure H; Matsuzawa M; Mitarai T
    Hypertens Res; 2013 Sep; 36(9):776-82. PubMed ID: 23615283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
    Baumann M; Janssen BJ; Hermans JJ; Peutz-Kootstra C; Witzke O; Smits JF; Struijker Boudier HA
    J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.